EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer

Yuhan Liu iD, Yuhan Zou, Yangli Ye, Yong Chen

Cancer Medicine · 2024

DOI: 10.1002/cam4.70410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2024. Verfasst von Yuhan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Resistance, Neoplasm, Mutation, Signal Transduction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation and Entrepreneurship Training Program for University Students of Shandong Second Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Triple‐negative breast cancer (TNBC) is a heterogeneous disease characterized by high aggressiveness, high malignancy, and poor prognosis compared to other breast cancer subtypes.

Objective

This review aims to explore recent advances in understanding TNBC and to provide new insights and potential references for clinical treatment.

Methods

We examined current literature on TNBC to analyze molecular subtypes, genetic mutations, signaling pathways, mechanisms of drug resistance, and emerging therapies.

Results

Findings highlight key aspects of TNBC's molecular subtypes, relevant mutations, and pathways, alongside emerging treatments that target drug resistance mechanisms.

Conclusion

These insights into TNBC pathogenesis may help guide future therapeutic strategies and improve clinical outcomes for patients with TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDrug Resistance, NeoplasmMutationSignal TransductionHumansFemaleBiomarkers, TumorMolecular Targeted TherapyPrognosis

Stichwörter der Autor:innen

classificationdrug resistancegenomic alterationssignaling pathwaystriple‐negative breast cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
  • College of Life Sciences and Technology, Shandong Second Medical University, Weifang, China.
  • Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China.

ORCID-Profile: Yuhan Liu

Förderung

  • National Natural Science Foundation of China
  • Innovation and Entrepreneurship Training Program for University Students of Shandong Second Medical University

Zitieren

APA

Liu, Y., Zou, Y., Ye, Y., & Chen, Y. (2024). Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70410

Vancouver

Liu Y, Zou Y, Ye Y, Chen Y. Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70410

BibTeX
@article{Liu2024,
  author = {Liu, Yuhan and Zou, Yuhan and Ye, Yangli and Chen, Yong},
  title = {Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70410}
}
Kostenlos starten →